Assay for characterization of human follicular oocyte maturation inhibitor using Xenopus oocytes.
Human follicular fluid from healthy mature Graafian follicles and from pathologic ovarian cyst fluid was found to be inhibitory to progesterone-induced meiotic maturation of oocytes from the South African clawed toad, Xenopus laevis. Human follicular fluid but not human serum, collected from the same individuals, demonstrated a linear dose-response inhibition on the maturation of oocytes in the Xenopus assay system. These findings indicate that the human follicular and cyst fluids contain oocyte maturation inhibitor (OMI). This human OMI was inactivated when subjected to a boiling water bath for 2 min. The OMI action was shown to be reversible in its inhibitory action. The fact that OMI can act directly on the oocyte was demonstrated by its inhibitory action on maturation in defolliculated oocytes. The findings demonstrate that the inhibitory action of human OMI is not species-specific. Xenopus oocytes provide a simple, readily available, year-round bioassay material for testing follicular oocyte maturation inhibitor.
D000818:Animals; D001826:Body Fluids / Q000032:analysis; D055598:Chemical Phenomena; D002621:Chemistry; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008540:Meiosis / Q000187:drug effects; D009865:Oocytes / Q000166:cytology*; D010048:Ovarian Cysts / Q000032:analysis; D006080:Ovarian Follicle / Q000032:analysis; D010063:Ovum / Q000166:cytology*; D010455:Peptides / Q000032:analysis* / Q000494:pharmacology; D014982:Xenopus laevis / Q000033:anatomy & histology*
D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; C018355:intraovarian peptides